Tris Pharma
Monmouth Junction, New Jersey, United States · Healthcare, Pharmaceutical Manufacturing
Tris Pharma, Inc. is a leading privately-owned biopharmaceutical company in the U.S. Our focus is on the development and commercialization of innovative medicines that address unmet patient needs and we have more than 150 U.S. and International patents including applications. We market several branded and generic products in the U.S; license our products in the U.S. and international markets and
Key facts
- Headquarters
- Monmouth Junction, New Jersey, United States
- Employees
- Unknown
- Industries
- Healthcare, Pharmaceutical Manufacturing
- Status
- Private
- Website
- trispharma.com
- Company page
Recent activity at Tris Pharma
- : Tris Pharma Announces Positive Results for Cebranopadol in Treating Acute Pain
- : Tris Pharma appoints Fowler as chief compliance officer, general counsel
- : Tris Pharma Appoints Franchesca Fowler to Chief Compliance Officer and Vice President, General Counsel
- : Tris Pharma Announces Acquisition Of New, Late-Stage Drug Candidate For Pain
- : Tris Pharma, Inc.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Tris Pharma funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2018 | Venture | $125.0M |
Leadership
- Ketan Mehta, Executive Officer, Director
- Smita Mehta, Director
- Franchesca Fowler, Chief Compliance Officer
- Peter Ciano, Executive Officer
Verified email and direct lines for Tris Pharma’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Tris Pharma files 5 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Tris Pharma in the news
- Tris Pharma Earns 2026 Great Place To Work Certification™ - GlobeNewswire (Oct 14, 2026)
- FDA Approves Tris Pharma’s Onyda XR, a Once-Daily, Extended-Release Oral Suspension for the Treatment of ADHD - Pharmaceutical Executive (May 30, 2024)
- Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD - Psychiatric Times (Apr 18, 2024)
- Tris Pharma Announces Acceptance of New Review Article Highlighting Challenges of Treating Moderate-to-Severe Acute Pain with Currently Available Drugs - Business Wire (Oct 16, 2025)
- Tris Pharma Named a BioSpace 2027 Best Places to Work Winner - The Manila Times (Nov 16, 2026)
- Pulse Health partners with Tris Pharma to Power Omnichannel HCP Engagement for ADHD Products - PR Newswire (Aug 06, 2025)
- Tris Pharma Announces FDA Acceptance of NDA for Once-Nightly, Low-Sodium Oxybate Product for Narcolepsy and Idiopathic Hypersomnia - Business Wire (Dec 09, 2025)
- Cranbury Pharmaceuticals Receives U.S. FDA Approval for First Generic Version of Emflaza - Business Wire (Jun 12, 2024)
Companies similar to Tris Pharma
- Mirum Pharmaceuticals, Inc. · Healthcare, Pharmaceutical Manufacturing
- Panbela Therapeutics · Healthcare, Pharmaceutical Manufacturing
- Elligo Health Research, Inc. · Healthcare, Pharmaceutical Manufacturing
- Zurex Pharma · Healthcare, Pharmaceutical Manufacturing
- Bridge Therapeutics · Healthcare, Pharmaceutical Manufacturing
About Tris Pharma: questions and answers
What does Tris Pharma do?
Tris Pharma, Inc. is a leading privately-owned biopharmaceutical company in the U.S. Our focus is on the development and commercialization of innovative medicines that address unmet patient needs and we have more than 150 U.S. and International patents including applications. We market several branded and generic products in the U.S; license our products in the U.S. and international markets and
Where is Tris Pharma headquartered?
Tris Pharma is headquartered in Monmouth Junction, New Jersey, United States.
Has Tris Pharma raised funding?
Yes. Fundz has recorded 1 funding event for Tris Pharma. The most recent, $125.0M, was in Oct 2018.
What is the latest news on Tris Pharma?
On Jan 22, 2025, Tris Pharma Announces Positive Results for Cebranopadol in Treating Acute Pain
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy